NUTRITIONAL THERAPY FOR PREGNANT-WOMEN WITH A METABOLIC DISORDER

Newborn screening programs have resulted in normal development primarily in women with phenylketonuria, galactosemia, and homocystinuria. These women are in their reproductive stages of life. They need specialized treatment resources for optimal fetal outcome. There are a host of other metabolic disorders; however, clinical experience with these disorders is so limited that specific guidelines for therapy are largely unavailable.